{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T23:35:20Z","timestamp":1764372920192,"version":"3.46.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,28]]},"DOI":"10.7759\/cureus.98037","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T23:31:07Z","timestamp":1764372667000},"source":"Crossref","is-referenced-by-count":0,"title":["Oral Malignant Melanoma Achieving Long-Term Survival With Nivolumab Monotherapy Following Surgical Treatment: A Report of a Rare Case"],"prefix":"10.7759","author":[{"given":"Shihomi","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Todoroki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhisa","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingo","family":"Kusukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0975-5950.183856","article-title":"Primary malignant melanoma of oral cavity: a tertiary care center experience","volume":"6","author":"Kumar V","year":"2015","unstructured":"Kumar V, Vishnoi JR, Kori CG, Gupta S, Misra S, Akhtar N. Primary malignant melanoma of oral cavity: a tertiary care center experience. Natl J Maxillofac Surg. 2015, 6:167-71. 10.4103\/0975-5950.183856","journal-title":"Natl J Maxillofac Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/01.cmr.0000215042.53683.40","article-title":"Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma","volume":"16","author":"Garc\u00eda M","year":"2006","unstructured":"Garc\u00eda M, del Muro XG, Tres A, et al.. Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma. Melanoma Res. 2006, 16:365-70. 10.1097\/01.cmr.0000215042.53683.40","journal-title":"Melanoma Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2005.00052.x","article-title":"Cutaneous melanoma: available therapy for metastatic disease","volume":"19","author":"Tarhini AA","year":"2006","unstructured":"Tarhini AA, Agarwala SS. Cutaneous melanoma: available therapy for metastatic disease. Dermatol Ther. 2006, 19:19-25. 10.1111\/j.1529-8019.2005.00052.x","journal-title":"Dermatol Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-015-0741-0","article-title":"Local anesthetic thoracoscopy for the diagnosis of metastatic pleural melanoma originated from oral malignant melanoma: case report and comments","volume":"13","author":"Yang B","year":"2015","unstructured":"Yang B, Li Q, Zhao H, Liu H, Tang T, Jiang C. Local anesthetic thoracoscopy for the diagnosis of metastatic pleural melanoma originated from oral malignant melanoma: case report and comments. World J Surg Oncol. 2015, 13:326. 10.1186\/s12957-015-0741-0","journal-title":"World J Surg Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5227\/skincancer.37.67","article-title":"Guide to drug therapy for malignant melanoma, version 1 2022 [Article in Chinese]","volume":"37","author":"Yamasaki N","year":"2022","unstructured":"Yamasaki N, Isei D, Uhara H, Kiyohara Y, Takenouchi T. Guide to drug therapy for malignant melanoma, version 1 2022 [Article in Chinese]. Ski Cancer. 2022, 37:67-71. 10.5227\/skincancer.37.67","journal-title":"Ski Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17740","article-title":"Japanese Dermatological Association Guidelines: clinical questions of guidelines for melanoma 2025","volume":"52","author":"Fukushima S","year":"2025","unstructured":"Fukushima S, Ito T, Asai J, et al.. Japanese Dermatological Association Guidelines: clinical questions of guidelines for melanoma 2025. J Dermatol. 2025, 52:e666-97. 10.1111\/1346-8138.17740","journal-title":"J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12603","article-title":"Clinical investigation of 38 cases of oral mucosal melanoma: a multicentre retrospective analysis in Japan","volume":"58","author":"Yamada SI","year":"2017","unstructured":"Yamada SI, Kurita H, Kamata T, et al.. Clinical investigation of 38 cases of oral mucosal melanoma: a multicentre retrospective analysis in Japan. Australas J Dermatol. 2017, 58:e223-7. 10.1111\/ajd.12603","journal-title":"Australas J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-021-01860-z","article-title":"Clinical outcomes and patterns of failure of head and neck mucosal melanoma treated with multiple treatment modalities","volume":"16","author":"Xu QQ","year":"2021","unstructured":"Xu QQ, Lai YZ, Huang ZL, et al.. Clinical outcomes and patterns of failure of head and neck mucosal melanoma treated with multiple treatment modalities. Radiat Oncol. 2021, 16:138. 10.1186\/s13014-021-01860-z","journal-title":"Radiat Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0975-5950.69165","article-title":"Metastatic malignant melanoma of palate: a review of literature and report of an unusual case","volume":"1","author":"Ram H","year":"2010","unstructured":"Ram H, Mohammad S, Husain N, Devi S, Gupta PN. Metastatic malignant melanoma of palate: a review of literature and report of an unusual case. Natl J Maxillofac Surg. 2010, 1:63-6. 10.4103\/0975-5950.69165","journal-title":"Natl J Maxillofac Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2024.05.006","article-title":"Targeted therapy innovations for melanoma","volume":"38","author":"Amarillo D","year":"2024","unstructured":"Amarillo D, Flaherty KT, Sullivan RJ. Targeted therapy innovations for melanoma. Hematol Oncol Clin North Am. 2024, 38:973-95. 10.1016\/j.hoc.2024.05.006","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920922028","article-title":"Immune checkpoint inhibitors in advanced or metastatic mucosal melanoma: a systematic review","volume":"12","author":"Li J","year":"2020","unstructured":"Li J, Kan H, Zhao L, Sun Z, Bai C. Immune checkpoint inhibitors in advanced or metastatic mucosal melanoma: a systematic review. Ther Adv Med Oncol. 2020, 12:1758835920922028. 10.1177\/1758835920922028","journal-title":"Ther Adv Med Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.9258","article-title":"Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis","volume":"35","author":"D'Angelo SP","year":"2017","unstructured":"D'Angelo SP, Larkin J, Sosman JA, et al.. Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis. J Clin Oncol. 2017, 35:226-35. 10.1200\/JCO.2016.67.9258","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23509","article-title":"Radiation therapy for advanced and metastatic melanoma","volume":"109","author":"Fogarty GB","year":"2014","unstructured":"Fogarty GB, Hong A. Radiation therapy for advanced and metastatic melanoma. J Surg Oncol. 2014, 109:370-5. 10.1002\/jso.23509","journal-title":"J Surg Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00610","article-title":"Chemoradiation increases PD-L1 expression in certain melanoma and glioblastoma cells","volume":"7","author":"Derer A","year":"2016","unstructured":"Derer A, Spiljar M, B\u00e4umler M, Hecht M, Fietkau R, Frey B, Gaipl US. Chemoradiation increases PD-L1 expression in certain melanoma and glioblastoma cells. Front Immunol. 2016, 7:610. 10.3389\/fimmu.2016.00610","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0574-6","article-title":"Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma","volume":"58","author":"Goforth R","year":"2009","unstructured":"Goforth R, Salem AK, Zhu X, Miles S, Zhang XQ, Lee JH, Sandler AD. Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma. Cancer Immunol Immunother. 2009, 58:517-30. 10.1007\/s00262-008-0574-6","journal-title":"Cancer Immunol Immunother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.01.017","article-title":"The synergistic effect of radiotherapy and immunotherapy: a promising but not simple partnership","volume":"111","author":"Chajon E","year":"2017","unstructured":"Chajon E, Castelli J, Marsiglia H, De Crevoisier R. The synergistic effect of radiotherapy and immunotherapy: a promising but not simple partnership. Crit Rev Oncol Hematol. 2017, 111:124-32. 10.1016\/j.critrevonc.2017.01.017","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal effect in a patient with melanoma","volume":"366","author":"Postow MA","year":"2012","unstructured":"Postow MA, Callahan MK, Barker CA, et al.. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med. 2012, 366:925-31. 10.1056\/NEJMoa1112824","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/426793-oral-malignant-melanoma-achieving-long-term-survival-with-nivolumab-monotherapy-following-surgical-treatment-a-report-of-a-rare-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T23:31:20Z","timestamp":1764372680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/426793-oral-malignant-melanoma-achieving-long-term-survival-with-nivolumab-monotherapy-following-surgical-treatment-a-report-of-a-rare-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.98037","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}